Restore Mind Medicine
CEO Robert Barrow
2009: Barrow graduates Wake Forest with a B.S. in Finance.
2009: Barrow joins Olatec Therapeutics as VP of Operations.
Olatec Therapeutics focuses on the development of topical gels which have a simpler
regulatory pathway and simpler clinical trials compared to psychedelics.
2018: Barrow enrolls in a Masters program and leaves Olatec. Olatec has not rehired his position.
2019: Barrow joins the Usona Institute where he was Director of Drug Development.
ā He purports to have helped gain Breakthrough Designation for psilocybin; however,
Usona's press release places the credit with the Director of Clinical Development.
2020: Barrow leaves Usona, his role was not rehired. Barrow joins MindMed as consultant.
2021: Barrow joins MindMed as Chief Development Officer; then is appointed CEO.
Source: Company SEC Filings, Usona Institute Press Releases, archive.org. See [5]
31View entire presentation